IL6 and type 2 diabetes mellitus: The ability of BRI to predict type 2 diabetes and cardiovascular risk stems from its accuracy in estimating visceral adiposity, which produces adipokines and inflammatory cytokines such as TNF-α, IL-6, and resistin, which impair insulin signaling pathways (96).